Clik here to view.
Announcing Our Exclusive Healthcare Summit Feb. 21: Request an Invite
Angela Shah Advances in genomics, mobile technology, and data collection and analysis are poised to transform healthcare from drug development to patient care and hospital management. But what will it …
View ArticleClik here to view.
The Big Guys Have Lost Their Iron Grip, and It’s All Good
Luke Timmerman Thinking about Big Pharma’s relationship with the biotech industry last week at the JP Morgan Healthcare Conference in San Francisco reminded me of an old physical education teacher …
View ArticleClik here to view.
Early Bird Ends Soon for Feb. 21 Healthcare Summit: Get Your Invite
Angela Shah Innovations in the lab, in software, and in how doctors, hospitals, patients, and scientists view the world and relate to each other are transforming the way healthcare is …
View ArticleClik here to view.
Precision Medicine Healthcare Summit on Feb. 21: Here’s the agenda
Angela Shah Let’s get personal: about medicine, healthcare, and how it’s delivered, that is. Join us for “Precision Medicine to Precision Management,” where we will bring together healthcare...
View ArticleClik here to view.
Precision Medicine Healthcare Summit, Feb. 21: Saver Rate Ends Today
Angela Shah We’re just a week away from “Precision Medicine to Precision Management,” where we bring together healthcare investors, entrepreneurs, and innovators in an exclusive, invitation-only...
View ArticleClik here to view.
San Diego’s StackIQ Gets First-Day Funding Boost on OurCrowd Website
Bruce V. Bigelow StackIQ, which provides Software-as-a-Service for managing “Big Data” computing systems, said today it is the first San Diego startup selected to raise capital from accredited...
View ArticleClik here to view.
Get a Shot, Have Some Bread: ImmusanT’s Plan For a Celiac Vaccine
Ben Fidler For people with celiac disease, there’s one way to avoid symptoms: don’t eat gluten. But what if a vaccine and some booster shots could let you eat all …
View ArticleOtonomy Raises $49M to Advance 3 Drugs for Treating Ear Diseases
Bruce V. Bigelow Otonomy, the San Diego biopharmaceutical startup developing new treatments for diseases and disorders of the ear, has refined its strategy, raised capital, and advanced three drug...
View ArticleSan Diego’s Synthorx Adds To Genetic Alphabet, Aims for Bio-Products
Bruce V. Bigelow [Corrected 5/7/14, 2 pm See below.] A group of scientists in San Diego who found a way to insert synthesized nucleotides into DNA—and who succeeded …
View ArticleBIO 2014: Training Bio-Entrepreneurs to Use Coffee, Yoga, and Data
Court Turner Editor’s note: Court Turner was a speaker in the bootcamp for biotechnology entrepreneurship at this week’s BIO 2014 Convention in San Diego. —BVB As a venture partner at …
View ArticleClik here to view.
Avalon-GSK Collaboration Generates Two More Startups in San Diego
Bruce V. Bigelow San Diego’s Avalon Ventures is taking the wraps off two new startups today, with each one getting as much as $10 million in Series A financing through …
View ArticleClik here to view.
ImmusanT Grabs $12M as Celiac Vaccine Hits Critical Proving Ground
Ben Fidler ImmusanT is trying to prove that a vaccine it’s developing can help celiac patients eat gluten without getting sick. Today, the Cambridge, MA-based company got enough dough to (Read more...)
View ArticleClik here to view.
J.P. Morgan 2015: Notes, Thoughts, And Conversations From the Vortex
Alex Lash The word “story” gets ill treatment at events like the J.P. Morgan Healthcare Conference. It often means an elevator pitch from a harried CEO to a distracted (Read more...)
View ArticleClik here to view.
In the Jiu-Jitsu Match of Biotech Risk, a Reminder of Other Paths
Alex Lash Risk makes for great headlines. I’m guilty as charged. My first column for Xconomy questioned whether biotech venture capitalists were losing relevance, running away from risk in (Read more...)
View ArticleClik here to view.
Built for a Deal, Annovation Rewards Backers With Medicines Co. Buyout
Ben Fidler These days, it seems biotech investors are happy to take all kinds of risk. But there are still times to hedge bets, which Atlas Venture did a few (Read more...)
View Article